Literature DB >> 12588914

Raised plasma oxidised LDL in acute cerebral infarction.

M Uno1, K T Kitazato, K Nishi, H Itabe, S Nagahiro.   

Abstract

BACKGROUND: The association between oxidised low density lipoprotein (OxLDL) and cerebral infarction is suspected but not established.
OBJECTIVES: To determine whether plasma OxLDL is a useful marker for monitoring oxidative stress in stroke patients.
METHODS: Plasma OxLDL concentrations were determined in 56 stroke patients with cerebral infarction (n = 45) or cerebral haemorrhage (n = 11), and in 19 age matched controls, using a novel sandwich enzyme linked immunosorbent assay.
RESULTS: Compared with the controls (0.130 (0.007) ng/ micro g LDL, mean (SEM)), OxLDL was significantly raised in patients with cerebral infarction (0.245 (0.022); p < 0.0001) but not in those with haemorrhage (0.179 (0.023)). Patients with cortical ischaemic infarcts (n = 22) had higher OxLDL levels than either the controls (p < 0.0001) or the patients with non-cortical ischaemic infarcts (n = 23) (p < 0.001). Increased OxLDL concentrations in patients with cortical infarcts persisted until the third day after stroke onset. The National Institutes of Health stroke scales in patients with cortical infarction were higher than in those with non-cortical infarction (p < 0.01).
CONCLUSIONS: There is a significant association between raised plasma OxLDL and acute cerebral infarction, especially cortical infarction. Plasma OxLDL may reflect oxidative stress in stroke patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12588914      PMCID: PMC1738343          DOI: 10.1136/jnnp.74.3.312

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  28 in total

1.  Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease.

Authors:  S Toshima; A Hasegawa; M Kurabayashi; H Itabe; T Takano; J Sugano; K Shimamura; J Kimura; I Michishita; T Suzuki; R Nagai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-10       Impact factor: 8.311

2.  Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes.

Authors:  S Ehara; M Ueda; T Naruko; K Haze; A Itoh; M Otsuka; R Komatsu; T Matsuo; H Itabe; T Takano; Y Tsukamoto; M Yoshiyama; K Takeuchi; J Yoshikawa; A E Becker
Journal:  Circulation       Date:  2001-04-17       Impact factor: 29.690

3.  Classification and natural history of clinically identifiable subtypes of cerebral infarction.

Authors:  J Bamford; P Sandercock; M Dennis; J Burn; C Warlow
Journal:  Lancet       Date:  1991-06-22       Impact factor: 79.321

4.  Oxidized LDL in carotid plaques and plasma associates with plaque instability.

Authors:  Kyoko Nishi; Hiroyuki Itabe; Masaaki Uno; Keiko T Kitazato; Hidehisa Horiguchi; Kiyohito Shinno; Shinji Nagahiro
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-10-01       Impact factor: 8.311

5.  Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins.

Authors:  T B Rajavashisth; A Andalibi; M C Territo; J A Berliner; M Navab; A M Fogelman; A J Lusis
Journal:  Nature       Date:  1990-03-15       Impact factor: 49.962

6.  Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells.

Authors:  S D Cushing; J A Berliner; A J Valente; M C Territo; M Navab; F Parhami; R Gerrity; C J Schwartz; A M Fogelman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

7.  Age-related reduction of NO availability and oxidative stress in humans.

Authors:  S Taddei; A Virdis; L Ghiadoni; G Salvetti; G Bernini; A Magagna; A Salvetti
Journal:  Hypertension       Date:  2001-08       Impact factor: 10.190

8.  Effect of losartan in aging-related endothelial impairment.

Authors:  Sanjay Rajagopalan; Robert Brook; Rajendra H Mehta; Mark Supiano; Bertram Pitt
Journal:  Am J Cardiol       Date:  2002-03-01       Impact factor: 2.778

9.  Measurements of acute cerebral infarction: lesion size by computed tomography.

Authors:  T Brott; J R Marler; C P Olinger; H P Adams; T Tomsick; W G Barsan; J Biller; R Eberle; V Hertzberg; M Walker
Journal:  Stroke       Date:  1989-07       Impact factor: 7.914

10.  Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.

Authors:  S Ylä-Herttuala; W Palinski; M E Rosenfeld; S Parthasarathy; T E Carew; S Butler; J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

View more
  30 in total

1.  Diabetes insipidus contributes to traumatic brain injury pathology via CD36 neuroinflammation.

Authors:  Theo Diamandis; Chiara Gonzales-Portillo; Gabriel S Gonzales-Portillo; Meaghan Staples; Mia C Borlongan; Diana Hernandez; Sandra Acosta; Cesar V Borlongan
Journal:  Med Hypotheses       Date:  2013-08-30       Impact factor: 1.538

2.  Nuclear factor-kappaB activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion.

Authors:  Alexander Kunz; Takato Abe; Karin Hochrainer; Munehisa Shimamura; Josef Anrather; Gianfranco Racchumi; Ping Zhou; Costantino Iadecola
Journal:  J Neurosci       Date:  2008-02-13       Impact factor: 6.167

3.  Serum Levels of Thioredoxin Are Associated with Stroke Risk, Severity, and Lesion Volumes.

Authors:  Meng-Hai Wu; Fang-Yu Song; Li-Ping Wei; Zhao-Yun Meng; Zhi-Qiang Zhang; Qin-De Qi
Journal:  Mol Neurobiol       Date:  2014-12-19       Impact factor: 5.590

4.  The class B scavenger receptor CD36 mediates free radical production and tissue injury in cerebral ischemia.

Authors:  Sunghee Cho; Eun-Mi Park; Maria Febbraio; Josef Anrather; Laibaik Park; Gianfranco Racchumi; Roy L Silverstein; Costantino Iadecola
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

Review 5.  Oxidative modification of LDL: its pathological role in atherosclerosis.

Authors:  Hiroyuki Itabe
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

6.  The relationship between serum lipoprotein (a) levels and ischemic stroke risk: a cohort study in the Chinese population.

Authors:  Shao-yi Li; Yun Gao; Wei-ning Ma; Hua-chao Wang; Gang Zhou; Wen-chang Guo; Yun-hui Liu
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

7.  Targeting CD36-mediated inflammation reduces acute brain injury in transient, but not permanent, ischemic stroke.

Authors:  Eun-Hee Kim; Aaron T Tolhurst; Hazel H Szeto; Sung-Hee Cho
Journal:  CNS Neurosci Ther       Date:  2014-09-12       Impact factor: 5.243

8.  Exposure to traffic-generated air pollutants mediates alterations in brain microvascular integrity in wildtype mice on a high-fat diet.

Authors:  Usa Suwannasual; JoAnn Lucero; Jacob D McDonald; Amie K Lund
Journal:  Environ Res       Date:  2017-11-05       Impact factor: 6.498

9.  Cerebrovascular dysfunction and blood-brain barrier permeability induced by oxidized LDL are prevented by apocynin and magnesium sulfate in female rats.

Authors:  Malou P H Schreurs; Marilyn J Cipolla
Journal:  J Cardiovasc Pharmacol       Date:  2014-01       Impact factor: 3.105

Review 10.  CD36 as a therapeutic target for endothelial dysfunction in stroke.

Authors:  Sunghee Cho
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.